healthcare News
Corvus shares surge on strong eczema data despite Q4 miss
$189M financing extends runway to 2028 as Phase 2 trial begins
Filana surges 12% on EPS beat amid tight cash runway
Former Cassava Sciences rebrands, but clinical hold on epilepsy program and litigation payment raise sustainability concerns
BridgeBio shares fall 3.9% despite landmark trial results for rare muscle disorder
BBP-418 demonstrates consistent efficacy in Phase 3 FORTIFY study, positioning company for first FDA-approved LGMD therapy
Guardian Pharmacy surges after earnings beat, guidance boost
Provider posts 57% EPS beat in Q4, swings to $49M full-year profit as EBITDA forecast lifted
Sagimet beats estimates on lower burn, advances MASH combo therapy
Cash position of $113M provides runway as biotech prepares for Phase 2 F4 MASH trial in 2026
Artiva Biotherapeutics surges 6.5% after earnings miss
FDA Fast Track designation for AlloNK in refractory rheumatoid arthritis outweighs wider-than-expected quarterly loss
Shoulder Innovations surges on Q4 revenue beat, guidance raise
Medical device company posts 65% revenue growth and raises 2026 outlook on robotic surgery momentum
ADC Therapeutics surges on earnings beat, $261M cash runway fuels optimism
Biotech company narrows losses to $6.4M with ZYNLONTA Phase 3 data expected next quarter